BioLineRx to Report Second Quarter 2025 Results on August 14, 2025
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BioLineRx (NASDAQ: BLRX), a development stage biopharmaceutical company focused on oncology and rare diseases, will release its Q2 2025 financial results on August 14, 2025, before U.S. markets open.
The company will host a conference call at 8:30 a.m. EDT featuring CEO Philip Serlin. Investors can access the call through U.S. dial-in (+1-888-281-1167) or international dial-in (+972-3-918-0685). A live webcast and replay will be available on the company's website, with the call replay accessible until August 16, 2025.
Details
News Market Reaction – BLRX
On Aug 7, the day this news came out, BLRX closed 6.17% below the previous close.
Data tracked by StockTitan Argus for the Aug 7 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Management to Hold Conference Call at 8:30 a.m. EDT

The Company will host a conference call at 8:30 a.m. EDT featuring remarks by Philip Serlin, Chief Executive Officer.
To access the conference call, please dial +1-888-281-1167 from the
About BioLineRx
BioLineRx Ltd. (NASDAQ/TASE: BLRX) is a biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases. The Company's first approved product is APHEXDA® (motixafortide), with an indication in the
Learn more about who we are, what we do, and how we do it at www.biolinerx.com or on LinkedIn.
CONTACTS:
Irina Koffler
LifeSci Advisors, LLC
IR@biolinerx.com
Moran Meir
LifeSci Advisors, LLC
moran@lifesciadvisors.com
Logo: https://mma.prnewswire.com/media/2154863/BioLineRx_Ltd_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/biolinerx-to-report-second-quarter-2025-results-on-august-14-2025-302524198.html
SOURCE BioLineRx Ltd.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.